SCHEMBL2860402

SCHEMBL2860402

Nc1ccc(Oc2cc(NC(=O)O)c(F)cc2Cl)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
KDM4E B2RXH2 4/20 0.43
POLB P06746 3/20 0.43
KEAP1 Q14145 1/20 0.40
ALOX5AP P20292 2/20 0.39
FEN1 P39748 2/20 0.39
GRM8 O00222 1/20 0.38
GRM7 Q14831 1/20 0.38
GRM4 Q14833 1/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
MET P08581 2/20 0.35
ALDH1A1 P00352 1/20 0.34
BRCA1 P38398 1/20 0.34
HBB P68871 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855457 0.89 MEN1 (0.50) MEN1KMT2AKDM4EPOLBKEAP1
SCHEMBL2855458 0.88 KMT2A (0.44) MEN1KMT2AKDM4EPOLBKEAP1
SCHEMBL2857489 0.82 HSPB1 (0.54) MEN1KMT2AKDM4EPOLBLMNA
SCHEMBL2857491 0.82 HSPB1 (0.54) MEN1KMT2AKDM4EPOLBLMNA
SCHEMBL2852227 0.80 KDM4E (0.52) MEN1KMT2AKDM4EPOLBKEAP1
SCHEMBL2864471 0.78 BRAF (0.37) LMNAMETALDH1A1NPC1RAB9A
SCHEMBL4314966 0.77 MEN1 (0.53) MEN1KMT2AKDM4EKEAP1ALOX5AP
SCHEMBL2860604 0.77 MEN1 (0.53) MEN1KMT2AKDM4EPOLBKEAP1
SCHEMBL2857370 0.76 BRAF (0.48)
SCHEMBL3510993 0.75 KMT2A (0.43) MEN1KMT2AKDM4EPOLBKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184285-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2015-11-04 EP disclosed
EP-2184285-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2010-05-12 EP disclosed